Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema

被引：45

作者：

Russo, Andrea ^{[1
]}

Costagliola, Ciro ^{[2
]}

Delcassi, Luisa ^{[1
]}

Parmeggiani, Francesco ^{[3
]}

Romano, Mario R. ^{[4
]}

dell'Omo, Roberto ^{[2
]}

Semeraro, Francesco ^{[1
]}

机构：

[1] Univ Brescia, Dept Neurol & Vis Sci, Eye Clin, I-25123 Brescia, Italy

[2] Univ Molise, Dept Hlth Sci, Eye Clin, I-86100 Campobasso, Italy

[3] Univ Ferrara, Dept Ophthalmol, I-44121 Ferrara, Italy

[4] Ist Clin Humanitas, Eye Clin, I-20089 Milan, Italy

来源：

MEDIATORS OF INFLAMMATION | 2013年 / 2013卷

关键词：

KETOROLAC TROMETHAMINE 0.5-PERCENT; ENDOTHELIAL GROWTH-FACTOR; SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; INDUCED OCULAR INFLAMMATION; EARLY DIABETIC-RETINOPATHY; FACTOR-H POLYMORPHISM; OPHTHALMIC SOLUTION; CATARACT-SURGERY; CHOROIDAL NEOVASCULARIZATION;

D O I：

10.1155/2013/476525

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Nonsteroidal anti-inflammatory drugs (NSAIDs) are nowadays widely used in ophthalmology to reduce eye inflammation, pain, and cystoid macular edema associated with cataract surgery. Recently, new topical NSAIDs have been approved for topical ophthalmic use, allowing for greater drug penetration into the vitreous. Hence, new therapeutic effects can be achieved, such as reduction of exudation secondary to age-related macular degeneration or diabetic maculopathy. We provide an updated review on the clinical use of NSAIDs for retinal diseases, with a focus on the potential future applications.

引用

页数：11

共 50 条

[41] NEPHROTOXICITY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
HAGLER, L
[J]. AMERICAN FAMILY PHYSICIAN, 1984, 30 (05) : 27 - 29
[42] Nonsteroidal anti-inflammatory drugs and pharyngitis
Mazzone, Stuart B.
Kulasekaran, Anuradha
Shea, Tim
Adegoke, Oluwajoba
[J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (12)
[43] A review of nonsteroidal anti-inflammatory drugs
Schellack, Natalie
Schellack, Gustav
Fourie, Johani
[J]. SA PHARMACEUTICAL JOURNAL, 2015, 82 (03) : 8 - 18
[44] The nonsteroidal anti-inflammatory drugs controversy
Yeomans, ND
Garas, G
Hawkey, CJ
[J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2000, 29 (04) : 791 - +
[45] Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
Kim, Stephen J.
Flach, Allan J.
Jampol, Lee M.
[J]. SURVEY OF OPHTHALMOLOGY, 2010, 55 (02) : 108 - 133
[46] PHOTOSENSITIVITY TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
FIGUEINEDO, A
TEIXEIRA, E
POIARESBAPTISTA, A
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (02) : 139 - 140
[47] Therapy with nonsteroidal, anti-inflammatory drugs
Bauer, H
Märker-Hermann, E
[J]. ORTHOPADE, 2003, 32 (12): : 1088 - 1094
[48] Novel nonsteroidal anti-inflammatory drugs
Boutsen, Y
Esselinckx, W
[J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 1999, 62 (04): : 421 - 424
[49] NONSTEROIDAL ANTI-INFLAMMATORY DRUGS - A REVIEW
ZARRO, V
[J]. AMERICAN FAMILY PHYSICIAN, 1984, 30 (05) : 243 - 246
[50] Nonsteroidal anti-inflammatory drugs and the kidney
Stürmer, T
Elseviers, MM
De Broe, ME
[J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 161 - 163

← 1 2 3 4 5 →